Svai Sanford - Jul 29, 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Financial Officer
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Svai Sanford
Stock symbol
RANI
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3/A - Amendment
Date filed
8/2/2021, 07:57 PM
Date Of Original Report
Jul 29, 2021
Next filing
Sep 13, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding RANI Class A Common LLC Units Jul 29, 2021 Class A Common Stock 142K Direct F1, F2
holding RANI Stock Option (Right to Buy) Jul 29, 2021 Class A Common Stock 211K $9.45 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Class A Common LLC Units of Rani Therapeutics, LLC, a direct subsidiary of the Issuer. The Class A Common LLC Units are exchangeable for shares of Class A Common Stock on a one-for-one basis at the discretion of the holder, subject to certain exceptions, conditions and adjustments, and have no expiration date.
F2 This amendment is being filed to correctly reflect the shares held.
F3 The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.
F4 This amendment is being filed to correctly reflect the exercise price of the Stock Option.